1. Home
  2. HRB vs RGEN Comparison

HRB vs RGEN Comparison

Compare HRB & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo H&R Block Inc.

HRB

H&R Block Inc.

HOLD

Current Price

$43.49

Market Cap

7.5B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$173.31

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRB
RGEN
Founded
1955
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HRB
RGEN
Price
$43.49
$173.31
Analyst Decision
Sell
Buy
Analyst Count
2
10
Target Price
$55.00
$174.90
AVG Volume (30 Days)
1.4M
560.1K
Earning Date
02-03-2026
02-19-2026
Dividend Yield
3.86%
N/A
EPS Growth
9.63
N/A
EPS
4.50
0.03
Revenue
$3,770,736,000.00
$707,890,000.00
Revenue This Year
$4.28
$17.84
Revenue Next Year
$3.14
$12.44
P/E Ratio
$9.66
$5,579.20
Revenue Growth
4.15
11.74
52 Week Low
$41.17
$102.97
52 Week High
$64.62
$182.52

Technical Indicators

Market Signals
Indicator
HRB
RGEN
Relative Strength Index (RSI) 48.48 65.21
Support Level $42.37 $162.21
Resistance Level $44.23 $167.65
Average True Range (ATR) 0.87 4.82
MACD 0.19 0.47
Stochastic Oscillator 53.33 82.67

Price Performance

Historical Comparison
HRB
RGEN

About HRB H&R Block Inc.

H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: